A five-year study shows that Stereotactic Body Radiation Therapy (SBRT) to treat prostate cancer offers a higher cure rate than more traditional approaches, according to researchers at UT Southwestern Medical Center Harold C. Simmons Comprehensive Cancer Center.
The study – the first trial to publish five-year results from SBRT treatment for prostate cancer – found a 98.6 percent cure rate with SBRT, a noninvasive form of radiation treatment that involves high-dose radiation beams entering the body through various angles and intersecting at the desired target. It is a state-of-the-art technology that allows for a concentrated dose to reach the tumor while limiting the radiation dose to surrounding healthy tissue.
“The high cure rate is striking when compared to the reported five-year cure rates from other approaches like surgery or conventional radiation, which range between 80 to 90 percent, while the side effects of this treatment are comparable to other types of treatment,” said Dr. Raquibul Hannan, Assistant Professor of Radiation Oncology and lead author for the study. “What we now have is a more potent and effective form of completely noninvasive treatment for prostate cancer, conveniently completed in five treatments.”
Conventional treatment options for early stage prostate cancer include:
- Prostatectomy, the surgical removal of the prostate gland, which can be done with minimally invasive techniques and robotic assistance;
- Brachytherapy, in which doctors implant numerous small radioactive seeds about the size of a grain of rice into the prostate gland using multiple large needles inserted through the skin in the operating room. Once implanted, the seeds release their radioactivity directly into the prostate gland; and
- External beam radiation, which involves 42 to 45 treatments administered over two or more months, five days a week.
“The current form of radiation is 44 treatments given over nine weeks. In contrast, the SBRT therapy we used allows the delivery of highly focused radiation in only five treatments, allowing patients to return to their normal lives more quickly,” said senior author Dr. Robert Timmerman, Director of the Annette Simmons Stereotactic Treatment Center at UT Southwestern, and Professor and Vice Chairman of the Department of Radiation Oncology. “SBRT is both more convenient and has increased potency.”
UT Southwestern served as the lead site for the multi-institutional clinical trial, which involved first-time prostate cancer patients diagnosed with stage I or stage II (low and intermediate risk) prostate cancer. A total of 91 patients were treated prospectively and followed for five years, with only one patient experiencing a recurrence of his cancer. The findings are published in the European Journal of Cancer.
Terry Martin of McKinney, Texas, – about an hour outside Dallas – said the fewer number of treatments was a compelling advantage when he was evaluating treatment options.
“I live 45 minutes away from UT Southwestern. The difference between being treated five times versus 44 times is enormous,” said Mr. Martin, a retired airline pilot. “I felt that I was back to normal just 10 days after finishing treatment.”
In addition to shorter treatment times, researchers found that side effects were not necessarily different compared to other forms of prostate cancer treatment. In the short term, the side effects of SBRT can include urinary issues (urgency, frequency and burning) and rectal irritation, which are often temporary and reverse within four weeks of treatment. Researchers found a small risk of longer-term urinary and rectal complications, which is also comparable to conventional treatments. Decrease in erectile function was seen in 25 percent of patients, fewer than with conventional radiation or surgery, said Dr. Hannan.
The Latest on: Stereotactic Body Radiation Therapy
via Google News
The Latest on: Stereotactic Body Radiation Therapy
- Stereotactic Body Radiation Therapy – Dr. James Studton November 8, 2019 at 6:58 am
SAN ANGELO, Texas - The City of San Angelo is asking the public for their input and ideas about their Airport Master Plan. There will be a public meeting and workshop on November 14, 2019 at 6 p.m. in ...
- Emerging Application of Stereotactic Body Radiation Therapy for Gynecologic Malignancieson October 26, 2019 at 5:00 pm
Stereotactic body radiation therapy for gynecological malignancy. Depicted is a stereotactic body radiation therapy treatment example using 136 beamlets converging on a pelvic relapse of previously ...
- Emerging Applications of Stereotactic Body Radiation Therapy for Head and Neck Canceron October 24, 2019 at 5:00 pm
Stereotactic radiation therapy has been used as a boost or salvage therapy at recurrence for nasopharyngeal carcinoma. The use of stereotactic body radiation therapy for head and neck cancer has ...
- Stereotactic Body Radiation Therapy Market Size, Share, Opportunities, Development and Global Trend Analysis till 2025on September 25, 2019 at 9:34 pm
Sep 26, 2019 (The Expresswire) -- key Players Covered in the Stereotactic Body Radiation Therapy Market research report are Siemens, Medical Systems, Inc., Elekta AB, IBA Worldwide 2019, BD, Isoray ...
- Central-Airway Necrosis after Stereotactic Body-Radiation Therapyon September 18, 2019 at 5:00 pm
Stereotactic body-radiation therapy is a novel technique that aims to deliver higher doses of radiation to cancers in a more focused way. However, adjacent tissues also get higher doses and fatal ...
- Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Canceron July 9, 2019 at 7:32 am
This randomized phase III trial studies sorafenib tosylate and stereotactic body radiation therapy to see how well they work compared to sorafenib tosylate alone in treating patients with liver cancer ...
- When Surgery Is Not an Option in Renal Cell Carcinoma: The Evolving Role of Stereotactic Body Radiation Therapyon May 14, 2019 at 6:27 am
Historically, radiation therapy has played a limited role in the management of renal cell carcinoma because early studies showed that it had no benefit in the neoadjuvant or adjuvant settings. Thus, ...
- Maintenance Chemotherapy With or Without Stereotactic Body Radiation Therapy in Treating Patients With Stage IV Non-small Cell Lung Canceron April 9, 2019 at 3:20 pm
This randomized phase II/III trial studies how well giving maintenance chemotherapy with or without stereotactic body radiation therapy works in treating patients with stage IV non-small cell lung ...
- W.P. Holman Clinic commences stereotactic body radiation therapy serviceon February 16, 2019 at 10:30 pm
The technology provides access to stereotactic body radiation therapy – used to treat small tumours in the chest, abdomen and pelvis that cannot be removed surgically or treated with conventional ...
- Stereotactic Body Radiation Therapy (SBRT) to the Cheston December 11, 2018 at 4:00 pm
This information will help you prepare for stereotactic body radiation therapy (SBRT) at Memorial Sloan Kettering (MSK). It will help you know what to expect before, during, and after your treatment.
via Bing News